NCT02627950View on ClinicalTrials.gov

Impact of Morphine Treatment on Platelet Inhibition in Acute Myocardial Infarction

PHASE4CompletedINTERVENTIONAL
Enrollment

138

Participants

Timeline

Start Date

December 31, 2015

Primary Completion Date

October 31, 2018

Study Completion Date

October 31, 2018

Conditions
Acute Myocardial Infarction
Interventions
DRUG

Morphinhydrochloricum

5 mg morphine intravenously

DRUG

Metoclopramide

10 mg MCP intravenously

DRUG

Ticagrelor

180 mg ticagrelor orally

DRUG

Isotonic sodium chloride

10 ml NaCl 0.9% intravenously

Trial Locations (1)

23538

University of Luebeck, Lübeck

All Listed Sponsors
lead

University of Luebeck

OTHER

NCT02627950 - Impact of Morphine Treatment on Platelet Inhibition in Acute Myocardial Infarction | Biotech Hunter | Biotech Hunter